CADTH Canadian Drug Expert Committee recommendation. indication: atopic dermatitis. Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) :

Saved in:

Bibliographic Details
Online Access:	Full text
Corporate Author:	CADTH Canadian Drug Expert Committee (Author)
Format:	Electronic eBook
Language:	English
Published:	Ottawa (ON) : CADTH, 2020
Edition:	Final.
Series:	Common drug review clinical review report.
Subjects:	Dermatitis, Atopic > drug therapy. Antibodies, Monoclonal, Humanized > therapeutic use. Antibodies, Monoclonal, Humanized > economics. Cost-Benefit Analysis. Insurance, Health, Reimbursement. Canada.

Internet

Full text